US Patent Issued to Seed Health on July 15 for "Modulation of an individual's gut microbiome to address osteoporosis and bone disease" (Colorado, California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,662, issued on July 15, was assigned to Seed Health Inc. (Venice, Canada).

"Modulation of an individual's gut microbiome to address osteoporosis and bone disease" was invented by Tye Jensen (Telluride, Colo.) and Joseph E. Kovarik (Englewood, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various embodiments of the present invention are directed to the field of treating and preventing osteoporosis, with particular embodiments directed to a method of ameliorating, treating, or preventing osteoporosis in a human subject employing tomatidine, xylitol, rapamycin, etc., as well as modifying an individual's microbiome to reduce the likelihood of os...